Press releases

Xeptiva contributes to the growth of the Uruguayan scientific ecosystem

Scientists develop a vaccine for chronic pain in companion animals

Vaccine against chronic pain in animals

Uruguayan scientists developed a vaccine from synthetically designed proteins

Vaccine for chronic pain in companion animals shows promise in early trials

Uruguayan scientists developed the first vaccine for chronic pain in dogs and cats

Xeptiva moves closer to first vaccine for chronic pain in companion animals

Everything about Xeptiva Therapeutics

Josefina Correa (CEO) and Emiliano Trias (CSO) discussed about the biotech ecosystem in Uruguay and Xeptiva's technology

Veterinary School in Uruguay is looking for dogs with chronic pain for an experimental vaccine study.

Uruguayan scientists develop vaccine for chronic pain

Vaccines to alleviate chronic pain in pets

The Institut Pasteur and the start-up Xeptiva Therapeutics have developed a vaccine to treat pain in pets

Sergio Fogel will invest millions in a company run by two young Uruguayans

Entrepreneurships with sustainable DNA, four young people who opted for triple impact

Time to become an investment magnet

A Uruguayan start-up advances in therapy to block pain in dogs, cats and horses